From 2024 to 2028, the share of China's scientific publications among the world's top-cited in biochemistry, genetics, and molecular biology is forecasted to decline steadily from 8.6% to 7.75%. In 2023, this share was 8.81%. The year-on-year percentage change reveals a consistent decrease of approximately 1% to 3% annually, highlighting a gradual reduction in China's impact on high-citation publications in this field. The 5-year compound annual growth rate (CAGR) shows an average annual decline of around 2.5%.
Future trends to watch for include technological advancements and policy changes that could help China regain its competitive edge in high-impact scientific research. Additionally, increased collaboration and investment in innovative research areas can potentially reverse the downward trend.
